Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-3701
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics ; volume:7 ; number:1 ; day:25 ; month:10 ; year:2017 ; pages:1-14 ; date:12.2017
Cell & bioscience ; 7, Heft 1 (25.10.2017), 1-14, 12.2017
- Creator
-
He, Mingqian
- Contributor
-
Shi, Bingyin
SpringerLink (Online service)
- DOI
-
10.1186/s13578-017-0183-1
- URN
-
urn:nbn:de:1111-2017121814850
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- He, Mingqian
- Shi, Bingyin
- SpringerLink (Online service)
Other Objects (12)
Probiotics and microbiota composition
Gut microbiota, probiotics and diabetes
Exploring the effects of probiotics on olanzapine-induced metabolic syndrome through the gut microbiota
Microbiota and neurologic diseases: potential effects of probiotics
Intestinal microbiota in human health and disease: the impact of probiotics
Effects of gut microbiota and probiotics on Alzheimer’s disease
Targeting the microbiome: from probiotics to fecal microbiota transplantation
Probiotics in human gut microbiota can degrade host glycosaminoglycans
Chrysanthemum morifolium Ramat extract and probiotics combination ameliorates metabolic disorders through regulating gut microbiota and PPARα subcellular localization
Probiotics and the Microbiota-Gut-Brain Axis: Focus on Psychiatry
Gut microbiota of preterm infants supplemented with probiotics: sub-study of the ProPrems trial
The preterm gut microbiota and administration routes of different probiotics: a randomized controlled trial
Probiotics and microbiota composition
Gut microbiota, probiotics and diabetes
Exploring the effects of probiotics on olanzapine-induced metabolic syndrome through the gut microbiota
Microbiota and neurologic diseases: potential effects of probiotics
Intestinal microbiota in human health and disease: the impact of probiotics
Effects of gut microbiota and probiotics on Alzheimer’s disease
Targeting the microbiome: from probiotics to fecal microbiota transplantation
Probiotics in human gut microbiota can degrade host glycosaminoglycans
Chrysanthemum morifolium Ramat extract and probiotics combination ameliorates metabolic disorders through regulating gut microbiota and PPARα subcellular localization
Probiotics and the Microbiota-Gut-Brain Axis: Focus on Psychiatry
Gut microbiota of preterm infants supplemented with probiotics: sub-study of the ProPrems trial
The preterm gut microbiota and administration routes of different probiotics: a randomized controlled trial
Probiotics and microbiota composition
Gut microbiota, probiotics and diabetes
Exploring the effects of probiotics on olanzapine-induced metabolic syndrome through the gut microbiota
Microbiota and neurologic diseases: potential effects of probiotics
Intestinal microbiota in human health and disease: the impact of probiotics
Effects of gut microbiota and probiotics on Alzheimer’s disease
Targeting the microbiome: from probiotics to fecal microbiota transplantation
Probiotics in human gut microbiota can degrade host glycosaminoglycans
Chrysanthemum morifolium Ramat extract and probiotics combination ameliorates metabolic disorders through regulating gut microbiota and PPARα subcellular localization
Probiotics and the Microbiota-Gut-Brain Axis: Focus on Psychiatry
Gut microbiota of preterm infants supplemented with probiotics: sub-study of the ProPrems trial